remdesivir
Gilead says Veklury should work against COVID-19 variants
Phil Taylor
coronavirus, COVID-19, drug resistance, Gilead Sciences, remdesivir, Veklury
0 Comment
News/ News/ Sales and Marketing
Gilead Q3 revenue rise bolstered by $873m Veklury sales
Phil Taylor
coronavirus, COVID-19, Financial, Gilead Sciences, remdesivir, Veklury
0 Comment
Gilead’s remdesivir finally gets US approval
George Underwood
coronavirus, COVID-19, Gilead, remdesivir, Veklury
0 Comment
Gilead’s COVID-19 drug Veklury falls short in WHO’s global trial
Richard Staines
COVID-19, Gilead, infectious diseases, R&D, remdesivir
0 Comment
EU ramps up supply of COVID-19 vaccine, drugs
Phil Taylor
coronavirus, coronavirus vaccine, COVID-19, EU, European Commission, Gilead Sciences, Johnson & Johnson, remdesivir
0 Comment
News/ News/ R&D/ Top stories
Trial backs Lilly’s Olumiant plus remdesivir as combo COVID-19 therapy
Phil Taylor
coronavirus, COVID-19, Eli Lilly, Gilead Sciences, Olumiant, remdesivir
0 Comment
News/ News/ Sales and Marketing
Gilead files COVID-19 drug remdesivir with FDA
Richard Staines
coronavirus, COVID-19, infectious diseases, R&D, remdesivir
0 Comment
Pfizer signs deal with Gilead to manufacture COVID-19 antiviral remdesivir
Richard Staines
coronavirus, COVID-19, Gilead, infectious diseases, remdesivir
0 Comment